| Literature DB >> 28611744 |
Amanda J Kreuder1,2, Jennifer A Schleining1, Michael Yaeger3, Qijing Zhang2, Paul J Plummer1,2.
Abstract
Colonization of the gallbladder by enteric pathogens such as Salmonella typhi, Listeria monocytogenes, and Campylobacter jejuni is thought to play a key role in transmission and persistence of these important zoonotic agents; however, little is known about the molecular mechanisms that allow for bacterial survival within this harsh environment. Recently, a highly virulent C. jejuni sheep abortion (SA) clone represented by the clinical isolate IA3902 has emerged as the dominant cause for sheep abortion in the United States. Previous studies have indicated that the C. jejuni clone SA can frequently be isolated from the gallbladders of otherwise healthy sheep, suggesting that the gallbladder may serve as an important reservoir for infection. To begin to understand the molecular mechanisms associated with survival in the host gallbladder, C. jejuni IA3902 was exposed for up to 24 h to both the natural ovine host in vivo gallbladder environment, as well as ovine bile in vitro. Following exposure, total RNA was isolated from the bile and high throughput deep sequencing of strand specific rRNA-depleted total RNA was used to characterize the transcriptome of IA3902 under these conditions. Our results demonstrated for the first time the complete transcriptome of C. jejuni IA3902 during exposure to an important host environment, the sheep gallbladder. Exposure to the host environment as compared to in vitro bile alone provided a more robust picture of the complexity of gene regulation required for survival in the host gallbladder. A subset of genes including a large number of protein coding genes as well as seven previously identified non-coding RNAs were confirmed to be differentially expressed within our data, suggesting that they may play a key role in adaptation upon exposure to these conditions. This research provides valuable insights into the molecular mechanisms that may be utilized by C. jejuni IA3902 to colonize and survive within the inhospitable gallbladder environment.Entities:
Keywords: Campylobacter; RNAseq; bile; gallbladder; in vivo model; transcriptome
Year: 2017 PMID: 28611744 PMCID: PMC5447181 DOI: 10.3389/fmicb.2017.00940
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1Total CFU of . Standard plate counts were used to determine the initial starting inoculum amount which averaged 1011 total CFU for all in vivo and in vitro studies (indicated in the figure as a dashed red line). Standard plates counts were again used to determine the CFU/mL of viable C. jejuni following both in vivo and in vitro incubation for 2 or 24 h; this was then mutiplied by the total volume of bile collected to determine the total CFU of bacteria recovered. An average was then taken from the four replicates for each condition at each time point to demonstrate amount of starting material for RNA extraction under the different conditions.
Summary of the differences in numbers of genes with increased and decreased expression under either .
| Decreased expression | 105 | 7 | 96 | 6 | 10 | 4 | 54 | 7 |
| Increased expression | 283 | 10 | 420 | 14 | 102 | 7 | 248 | 11 |
| Decreased expression | [15] | [1] | [12] | [0] | [7] | [0] | [16] | [1] |
| Increased expression | [62] | [1] | [87] | [2] | [44] | [1] | [53] | [1] |
Chr, IA3902 chromosome;
pVir, pVir plasmid associated with IA3902;
[], signifies that this is a putative list generated by Rockhopper of predicted non-coding RNA as well as known non-coding RNA genes.
Figure 2Analysis of the differentially expressed genes based on COG function detected by RNAseq, gallbladder and 24 h (B) and bile in vitro samples at 2 h (C) and 24 h (D). Clusters of Orthologous Groups (COG) categories are indicated on the x-axis, with the percentage of genes enriched shown on the y-axis. Black bars indicate increased expression, patterned bars indicate decreased expression. Red asterisks (*) indicate statistically significant enrichment (p < 0.05) for genes with increased expression; blue asterisks (*) indicate statistically significant enrichment (p < 0.05) for genes with decreased expression. COG category codes: C, Energy production and conversion; D, Cell cycle control, mitosis and meiosis; E, Amino acid transport and metabolism; F, Nucleotide transport and metabolism; G, Carbohydrate transport and metabolism; H, Coenzyme transport and metabolism; I, Lipid transport and metabolism; J, Translation; K, Transcription; L, Replication, recombination and repair; M, Cell wall/membrane biogenesis; N, Cell motility; O, Posttranslational modification, protein turnover, chaperones; P, Inorganic ion transport and metabolism; Q, Secondary metabolites biosynthesis, transport and catabolism; R, General function prediction only; S, Function unknown; T, Signal transduction mechanisms; U, Intracellular trafficking and secretion; V, Defense mechanisms; W, Extracellular structures.
Figure 3Venn diagrams depicting the overlap of upregulated (A) and downregulated (B) annotated genes in all conditions compared to the unexposed IA3902 inoculum. Differential expression of all known annotated genes were compared to each other utilizing the Venny program.
List of annotated genes identified to be upregulated or downregulated under all four conditions when compared with the unexposed IA3902 inoculum.
| CJSA_0035 | MFS family drug resistance transporter | 3.5 | 3.3 | 2.0 | 3.7 |
| CJSA_0040 | Hypothetical protein | 21.4 | 52.2 | 10.9 | 15.1 |
| CJSA_0041 | Hypothetical protein | 3.1 | 6.1 | 1.6 | 2.2 |
| CJSA_0045 | Putative iron-binding protein | 2.8 | 5.3 | 3.8 | 4.2 |
| CJSA_0049 | Hypothetical protein | 1.9 | 3.9 | 1.5 | 1.6 |
| CJSA_0056 | Hypothetical protein | 3.0 | 10.6 | 1.6 | 3.2 |
| Hydroxymethyldihydropteridine pyrophosphokinase | 2.7 | 3.3 | 2.9 | 3.1 | |
| F0F1 ATP synthase subunit B | 2.7 | 4.1 | 1.9 | 2.5 | |
| CJSA_0126 | Hypothetical protein | 2.5 | 4.4 | 2.3 | 2.9 |
| CJSA_0166 | Putative lipoprotein | 4.8 | 12.4 | 2.2 | 3.5 |
| CJSA_0305 | Hypothetical protein | 2.8 | 4.9 | 1.5 | 2.8 |
| RND efflux system, inner membrane transporter CmeB | 3.7 | 1.7 | 1.7 | 1.9 | |
| RND efflux system, membrane fusion protein CmeA | 3.8 | 2.6 | 2.3 | 2.1 | |
| CJSA_0370 | Hypothetical protein | 3.2 | 6.6 | 2.6 | 5.0 |
| Succinate dehydrogenase, flavoprotein subunit | 6.5 | 2.4 | 2.5 | 1.5 | |
| Succinate dehydrogenase, iron-sulfur protein subunit | 5.0 | 2.0 | 2.5 | 1.5 | |
| CJSA_0426 | Hypothetical protein | 3.5 | 10.4 | 1.8 | 3.8 |
| CJSA_0528 | Hypothetical protein | 29.3 | 21.3 | 17.3 | 15.8 |
| Endonuclease III | 2.2 | 3.9 | 2.3 | 4.2 | |
| CJSA_0596 | Prophage Lp2 protein 6 | 1.5 | 2.4 | 1.5 | 2.1 |
| CJSA_0636 | Hypothetical protein | 2.2 | 2.8 | 1.5 | 2.3 |
| Flagellar basal body L-ring protein | 1.6 | 4.4 | 2.0 | 1.7 | |
| CJSA_0655 | Hypothetical protein | 2.4 | 4.9 | 1.6 | 3.9 |
| CJSA_0716 | Hypothetical protein | 2.9 | 2.8 | 1.7 | 1.7 |
| CJSA_0785 | Hypothetical protein | 2.8 | 9.7 | 2.3 | 6.2 |
| CJSA_0818 | Hypothetical protein | 2.7 | 1.6 | 2.7 | 2.2 |
| Putative disulfide oxidoreductase | 3.5 | 1.8 | 2.6 | 2.2 | |
| Flagellar hook-associated protein FlgL | 2.2 | 5.3 | 1.9 | 1.9 | |
| CJSA_0852 | Hypothetical protein | 1.9 | 4.2 | 1.5 | 2.0 |
| CJSA_0920 | Hypothetical protein | 2.0 | 3.7 | 2.3 | 1.5 |
| RNA polymerase sigma factor RpoD | 1.7 | 2.9 | 1.7 | 1.9 | |
| Membrane fusion component multidrug efflux system CmeDEF | 1.9 | 2.0 | 1.5 | 1.5 | |
| CJSA_0977 | Adenylosuccinate lyase | 2.5 | 5.2 | 2.4 | 3.4 |
| Transcription termination factor Rho | 1.8 | 1.9 | 1.6 | 1.7 | |
| CJSA_1129 | Putative PAS domain containing signal-transduction sensor | 4.8 | 5.7 | 1.8 | 2.1 |
| CJSA_1146 | Putative 5-formyltetrahydrofolate cyclo-ligase family protein | 1.6 | 4.1 | 1.6 | 2.3 |
| CJSA_1180 | Hypothetical protein | 2.1 | 7.1 | 1.9 | 2.1 |
| C4 aminotransferase specific for PseB product | 2.0 | 3.1 | 1.7 | 1.5 | |
| CJSA_1233 | Hypothetical protein | 2.7 | 3.9 | 1.6 | 1.7 |
| Motility accessory factor | 2.3 | 3.3 | 2.4 | 2.2 | |
| Putative UDP-N-acetylglucosamine 2-epimerase | 4.4 | 6.0 | 1.8 | 2.5 | |
| CJSA_1266 | Hypothetical protein | 1.6 | 4.1 | 1.6 | 2.3 |
| Motility accessory factor | 2.5 | 3.5 | 2.3 | 2.3 | |
| Putative periplasmic cytochrome C | 3.4 | 3.8 | 3.2 | 3.3 | |
| Putative periplasmic cytochrome C | 6.1 | 11.1 | 7.8 | 6.3 | |
| CJSA_1304 | Putative nucleotide phosphoribosyltransferase | 1.8 | 1.5 | 1.5 | 2.1 |
| CJSA_1387 | Hypothetical protein | 2.1 | 5.0 | 1.7 | 1.8 |
| Translation initiation factor IF-1 | 2.9 | 2.9 | 1.7 | 2.3 | |
| CJSA_1533 | Hypothetical protein | 1.8 | 2.2 | 1.9 | 2.2 |
| CJSA_1544 | Hypothetical protein | 2.9 | 6.7 | 3.1 | 3.8 |
| CJSA_1554 | Hypothetical protein | 1.8 | 2.3 | 1.5 | 2.2 |
| CJSA_1562 | Hypothetical protein | 2.6 | 4.5 | 1.5 | 2.1 |
| CJSA_1596 | Putative MSF family efflux protein | 3.9 | 4.0 | 3.1 | 4.0 |
| CJSA_1624 | GNAT family acetyltransferase | 3.0 | 7.3 | 1.7 | 2.5 |
| CJSA_pVir0024 | Putative plasmid partioning ParA protein | 1.7 | 4.1 | 4.2 | 4.5 |
| CJSA_pVir0025 | Hypothetical protein | 4.6 | 5.4 | 4.2 | 5.3 |
| Putative replication protein RepE | 3.4 | 10.9 | 4.3 | 6.5 | |
| CJSA_pVir0040 | Hypothetical protein | 3.5 | 8.1 | 2.5 | 3.9 |
| CJSA_pVir0044 | Hypothetical protein | 5.4 | 22.4 | 6.0 | 13.8 |
| CJSA_t0001 | Ala tRNA | 6.1 | 8.0 | 2.2 | 3.4 |
| CJSA_t0002 | Ile tRNA | 8.1 | 9.4 | 1.9 | 3.2 |
| CJSA_t0004 | Ala tRNA | 5.0 | 5.9 | 1.5 | 2.1 |
| CJSA_t0014 | Ala tRNA | 4.6 | 6.3 | 2.0 | 2.5 |
| CJSA_t0015 | Ile tRNA | 7.7 | 8.3 | 1.7 | 3.0 |
| CJSA_t0023 | Val tRNA | 2.2 | 4.7 | 1.7 | 1.5 |
| CJSA_t0043 | Ala tRNA | 1.9 | 3.8 | 1.6 | 1.9 |
| CJSA_t0044 | Val tRNA | 2.3 | 4.9 | 1.8 | 2.0 |
| CJSA_0025 | Sodium/dicarboxylate symporter | −7.2 | −3 | −2.4 | −7.6 |
| Putative amino-acid transporter periplasmic solute-binding | −5.3 | −4.2 | −3.5 | −3.7 | |
| 5,10-methylenetetrahydrofolate reductase | −2.7 | −2.2 | −4.2 | −6.3 | |
| Putative sodium/proline permease | −4.7 | −9 | −2.0 | −2.9 | |
| CJSA_1573 | ABC transporter permease | −2.1 | −1.9 | −2.9 | −7 |
| CJSA_pVir0008 | Hypothetical protein | −4.2 | −11.7 | −2.5 | −2.7 |
| CJSA_pVir0009 | Hypothetical protein | −3.8 | −10.6 | −2.4 | −2.7 |
| CJSA_pVir0050 | Hypothetical protein | −6.7 | −7.5 | −4.1 | −5.3 |
| CJSA_pVir0051 | Hypothetical protein | −5 | −5 | −4.4 | −5 |
| CJSA_t0030 | Ser tRNA | −7.4 | −4.2 | −3.6 | −6.9 |
A comparison of fold change under each condition is provided.
Bile, Bile only in vitro condition;
GB, Gallbladder in vivo condition.
List of annotated genes identified to be upregulated only under the .
| DsbB family disulfide bond formation protein | 2.1 | 2.7 | |
| Disulfide bond formation protein | 3.0 | 6.5 | |
| Flagellar motor switch protein FliM | 1.9 | 2.6 | |
| Flagellar biosynthesis sigma factor | 2.0 | 4.4 | |
| Cytochrome d ubiquinol oxidase, subunit I | 2.4 | 3.1 | |
| CJSA_0080 | Putative lipoprotein | 1.8 | 2.3 |
| GTPase ObgE | 1.5 | 3.4 | |
| CJSA_0111 | Putative recombination protein RecO | 5.4 | 5.6 |
| CJSA_0112 | Putative metalloprotease | 3.1 | 1.9 |
| Homoserine kinase | 2.2 | 2.0 | |
| CJSA_0149 | Cytochrome c family protein | 1.5 | 1.6 |
| CJSA_0150 | Putative 6-pyruvoyl tetrahydropterin synthase | 1.8 | 1.9 |
| CJSA_0228 | Hypothetical protein | 1.6 | 1.7 |
| CJSA_0233 | Sulfatase | 2.9 | 2.5 |
| Diacylglycerol kinase | 3.6 | 4.9 | |
| Dihydroorotase | 2.3 | 2.8 | |
| CJSA_0240 | Zinc transporter ZupT | 2.5 | 2.1 |
| Rod shape-determining protein MreC | 1.8 | 1.6 | |
| Lipid-A-disaccharide synthase | 1.6 | 1.7 | |
| Nucleoside diphosphate kinase | 1.8 | 1.9 | |
| Flagellar biosynthesis protein FlhB | 1.9 | 2.4 | |
| CJSA_0327 | Ppx/GppA family phosphatase | 1.8 | 1.7 |
| Ferredoxin, 4Fe-4S | 1.6 | 1.9 | |
| CJSA_0358 | Integral membrane protein | 1.5 | 1.6 |
| CJSA_0384 | GTP-binding protein | 2.7 | 2.6 |
| CJSA_0424 | Hypothetical protein | 3.1 | 2.7 |
| CJSA_0425 | Hypothetical protein | 2.5 | 3.3 |
| 50S ribosomal protein L33 | 1.5 | 2.3 | |
| CJSA_0467 | Hypothetical protein | 1.8 | 1.7 |
| CJSA_0474 | Gfo/Idh/MocA family oxidoreductase | 2.2 | 2.3 |
| CJSA_0517 | Hypothetical protein | 2.1 | 1.7 |
| CJSA_0572 | Putative polyphosphate kinase | 1.7 | 1.8 |
| CJSA_0575 | ABC-type transmembrane transport protein | 1.9 | 2.0 |
| DNA repair protein RecN | 1.5 | 1.7 | |
| CJSA_0699 | Hypothetical protein | 3.1 | 4.9 |
| CJSA_0717 | Hypothetical protein | 2.6 | 2.9 |
| Formyltetrahydrofolate deformylase | 1.5 | 2.2 | |
| Putative cell division protein | 2.1 | 2.8 | |
| CJSA_0894 | Peptidyl-arginine deiminase family protein | 2.1 | 1.7 |
| CJSA_0897 | Putative HAMP containing membrane protein | 2.0 | 2.0 |
| CJSA_0910 | Putative acyl-CoA thioester hydrolase | 2.2 | 2.7 |
| Sigma-54 associated transcriptional activator | 1.7 | 5.2 | |
| CJSA_0968 | Hypothetical protein | 2.1 | 5.3 |
| Single-stranded DNA-binding protein | 1.6 | 1.8 | |
| Transcription-repair coupling factor | 1.9 | 1.9 | |
| CJSA_1086 | Hypothetical protein | 3.1 | 5.3 |
| CJSA_1118 | ABC transporter ATP-binding protein | 2.2 | 3.9 |
| CJSA_1153 | Peptidase, M23/M37 family | 1.8 | 1.5 |
| Putative glutathione-regulated potassium-efflux system | 1.5 | 2.5 | |
| Excinuclease ABC subunit C | 3.3 | 4.4 | |
| CJSA_1190 | Hypothetical protein | 1.6 | 2.1 |
| Two-component sensor (histidine kinase) | 1.5 | 2.0 | |
| Putative K+ uptake protein | 1.9 | 1.7 | |
| Imidazole glycerol phosphate synthase subunit HisF | 2.3 | 1.5 | |
| Motility accessory factor | 2.1 | 1.7 | |
| CJSA_1305 | Putative periplasmic protein (VacJ-like protein) | 1.6 | 1.5 |
| CJSA_1416 | Hypothetical protein | 1.9 | 2.4 |
| Putative selenide, water dikinase | 1.7 | 1.9 | |
| CJSA_1448 | Hypothetical protein | 1.8 | 2.6 |
| 30S ribosomal protein S13 | 1.7 | 1.7 | |
| Ribonuclease H | 1.7 | 1.7 | |
| Glutamate racemase | 2.5 | 2.5 | |
| Putative lipoprotein nlpC | 1.7 | 1.8 | |
| Na+/H+ antiporter | 1.7 | 3.1 | |
| CJSA_1631 | Putative GTP cyclohydrolase I | 2.6 | 13.9 |
| CJSA_pVir0016 | Hypothetical protein | 2.9 | 2.6 |
| CJSA_pVir0020 | Hypothetical protein | 2.0 | 1.8 |
| CJSA_t0009 | Thr tRNA | 1.7 | 2.9 |
| CJSA_t0011 | Arg tRNA | 2.3 | 2.7 |
| CJSA_t0012 | Met tRNA | 1.6 | 4.4 |
| CJSA_t0020 | Val tRNA | 1.8 | 3.6 |
| CJSA_t0033 | Leu tRNA | 1.8 | 1.8 |
| CJSA_t0034 | Cys tRNA | 1.7 | 3.4 |
| CJSA_t0035 | Ser tRNA | 2.3 | 4.2 |
| CJSA_t0037 | Arg tRNA | 1.9 | 1.9 |
| CJSA_t0038 | Arg tRNA | 2.1 | 1.9 |
| CJSA_t0040 | Pro tRNA | 1.5 | 1.7 |
GB, Gallbladder in vivo condition.
Figure 4KEGG Pathway for flagellar assembly in Multiple genes responsible for flagellar assembly were observed to be upregulated in the gallbladder condition only; image depicts 24 h in the in vivo gallbladder environment (increased differential expression denoted by red highlight).
Summary of the number of genes found to be differentially expressed when the 2 and 24 h time points for each condition were compared to each other.
| Increased at 2 vs. 24 h | 38 | 16 |
| Increased at 24 vs. 2 h | 136 | 9 |
| Increased at 2 vs. 24 h | [4] | [8] |
| Increased at 24 vs. 2 h | [57] | [3] |
GB, Gallbladder in vivo condition.
Bile, Bile only in vitro condition.
Figure 5Venn diagrams depicting the overlap of upregulated (A) and downregulated (B) predicted non-coding RNA unannotated genes in all conditions compared to the unexposed IA3902 inoculum. All putative ncRNA predicted by Rockhopper as differentially expressed under each condition were compared to each other utilizing the Venny program.
List of previously validated .
| 250059-249960 | 99 | − | CjNC20 | CjSA_0232 | CjSA_0233 | <<< |
| 675392-675240 | 152 | − | CjNC60 | CjSA_0681 | ><> | |
| 1155464-1155580 | 116 | + | CjNC120 | >>< | ||
| 1193304-1193433 | 129 | + | CjNC140 | CjSA_1197 | >>> | |
| 1572367-1572461 | 94 | + | CjNC180 | CjSA_1562 | >>< | |
| 25244-25412 | 168 | + | CJpv2 | CjSA_pVir0032 | CjSA_pVir0032 | >>< |
| 1183928-1183941 | 13 | + | CjNC130/6S | CjSA_1188 | CjSA_1188 | >>> |
All ncRNAs identified were located within the intergenic regions of the left flanking (LFG) and right flanking (RFG) genes.
LFG, left flanking gene;
RFG, right flanking gene;
<<
><> or >><, flanking genes and ncRNA expressed in different directions.
Differential expression observed under each condition of previously validated non-coding RNAs (Dugar et al., .
| CjNC20 | 1.1 | |||
| CjNC60 | 0.8 | 1 | 1.3 | |
| CjNC120 | 1.3 | 1.1 | 1.2 | |
| CjNC140 | 1.4 | |||
| CjNC180 | ||||
| CJpv2 | −1.4 | −1.2 | −1.1 | |
| CjNC130/6S | − | − | −1.8 | −1.8 |
Q value >0.05 but fold change < 1.5.
fold change >1.5 but Q value < 0.05.
Bold indicates significant differential expression
GB, Gallbladder in vivo condition;
Bile, Bile only in vitro condition.
Fold change expression data for the 14 genes previously reported to be involved in the bile tolerance response in .
| Yes | Increase | Lin et al., | |||||
| Yes | Increase | Lin et al., | |||||
| Yes | 1.2 | Increase | Lin et al., | ||||
| Yes | 1.4 | Increase | Akiba et al., | ||||
| Yes | Increase | Akiba et al., | |||||
| Yes | 1.5 | 1.1 | 1.3 | Increase | Akiba et al., | ||
| Yes | 1.3 | 1.1 | 1.2 | None | Lin et al., | ||
| Yes | 1.1 | 1.0 | 1.4 | None | Raphael et al., | ||
| Yes | 0.8 | 1 | 0.9 | 1.4 | Increase | Rivera-Amill et al., | |
| Yes | 0.9 | 1 | 1.3 | 0.7 | Increase | Allen and Griffiths, | |
| Yes | NE | NE | NE | NE | Increase | Malik-Kale et al., | |
| Yes | 1.2 | 1.4 | 1.0 | 1.4 | Increase | Malik-Kale et al., | |
| No | − | − | − | − | − | Lertpiriyapong et al., | |
| No | − | − | − | − | − | Lertpiriyapong et al., | |
NE, not expressed under any conditions studied (<5 RMPK);
Q value > 0.05 but fold change < 1.5.
Bold indicates significant differential expression.
GB, Gallbladder in vivo condition;
Bile, Bile only in vitro condition.